Literature DB >> 6841282

Effects of N-acetylcysteine on kanamycin ototoxicity in the guinea pig.

G R Bock, G K Yates, J J Miller, P Moorjani.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6841282     DOI: 10.1016/0378-5955(83)90030-8

Source DB:  PubMed          Journal:  Hear Res        ISSN: 0378-5955            Impact factor:   3.208


× No keyword cloud information.
  6 in total

1.  Comparative analysis of combination kanamycin-furosemide versus kanamycin alone in the mouse cochlea.

Authors:  Keiko Hirose; Eisuke Sato
Journal:  Hear Res       Date:  2010-10-31       Impact factor: 3.208

2.  d-Methionine reduces tobramycin-induced ototoxicity without antimicrobial interference in animal models.

Authors:  Daniel J Fox; Morris D Cooper; Cristian A Speil; Melissa H Roberts; Susan C Yanik; Robert P Meech; Tim L Hargrove; Steven J Verhulst; Leonard P Rybak; Kathleen C M Campbell
Journal:  J Cyst Fibros       Date:  2015-07-10       Impact factor: 5.482

3.  Preventing amikacin related ototoxicity with N-acetylcysteine in patients undergoing peritoneal dialysis.

Authors:  Ismail Kocyigit; Alperen Vural; Aydin Unal; Murat Hayri Sipahioglu; Hasan Esat Yucel; Samet Aydemir; Cevat Yazici; M İlhan Sahin; Oktay Oymak; Bulent Tokgoz
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-07-30       Impact factor: 2.503

4.  A kinase inhibitor library screen identifies novel enzymes involved in ototoxic damage to the murine organ of Corti.

Authors:  Matthew Ryals; Kwang Pak; Rahul Jalota; Arwa Kurabi; Allen F Ryan
Journal:  PLoS One       Date:  2017-10-19       Impact factor: 3.240

Review 5.  Use of the guinea pig in studies on the development and prevention of acquired sensorineural hearing loss, with an emphasis on noise.

Authors:  Gaëlle Naert; Marie-Pierre Pasdelou; Colleen G Le Prell
Journal:  J Acoust Soc Am       Date:  2019-11       Impact factor: 2.482

Review 6.  N-Acetyl Cysteine as an Adjunct in the Treatment of Tuberculosis.

Authors:  Dawit A Ejigu; Solomon M Abay
Journal:  Tuberc Res Treat       Date:  2020-04-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.